The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
Abstract
CONTEXT: Bleeding complications with percutaneous coronary intervention (PCI) are associated with adverse patient outcomes. The association between the use of bleeding avoidance strategies and post-PCI bleeding as a function of a patient's preprocedural risk of bleeding is unknown. OBJECTIVE: To describe the use of 2 bleeding avoidance strategies, vascular closure devices and bivalirudin, and associated post-PCI bleeding rates in a nationally representative PCI population. DESIGN, SETTING, AND PATIENTS: Analysis of data from 1,522,935 patients undergoing PCI procedures performed at 955 US hospitals participating in the National Cardiovascular Data Registry (NCDR) CathPCI Registry from January 1, 2004, through September 30, 2008. MAIN OUTCOME MEASURE: Periprocedural bleeding. RESULTS: Bleeding occurred in 30,654 patients (2%). Manual compression, vascular closure devices, bivalirudin, or vascular closure devices plus bivalirudin were used in 35%, 24%, 23%, and 18% of patients, respectively. Bleeding events were reported in 2.8% of patients who received manual compression, compared with 2.1%, 1.6%, and 0.9% of patients receiving vascular closure devices, bivalirudin, and both strategies, respectively (P < .001). Bleeding rates differed by preprocedural risk assessed with the NCDR bleeding risk model (low risk, 0.72%; intermediate risk, 1.73%; high risk, 4.69%). In high-risk patients, use of both strategies was associated with lower bleeding rates (manual compression, 6.1%; vascular closure devices, 4.6%; bivalirudin, 3.8%; vascular closure devices plus bivalirudin, 2.3%; P < .001). This association persisted following adjustment using a propensity-matched and site-controlled model. Use of both strategies was used least often in high-risk patients (14.4% vs 21.0% in low-risk patients, P < .001). CONCLUSIONS: In a large national PCI registry, vascular closure devices and bivalirudin were associated with significantly lower bleeding rates, particularly among patients at greatest risk for bleeding. However, these strategies were less often used among higher-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“Absolute standardized differences were computed to evaluate matching effectiveness and displayed graphically(17-19); values less than 10% and closer to zero demonstrate a more balanced cohort.(17) Hierarchical modeling was then performed on the matched cohort to account for hospital characteristics.”
MethodRosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 4,774
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,908
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Bivalirudin during Primary PCI in Acute Myocardial Infarction
Stone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., Pocock, S. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708191 · Cited by 1,867
The role of the propensity score in estimating dose-response functions
Imbens, G. (2000) · Biometrika · doi:10.1093/biomet/87.3.706 · Cited by 1,776
Bivalirudin for Patients with Acute Coronary Syndromes
Stone, G. W., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., White, H. D., Pocock, S. J., Ware, J. H., Feit, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062437 · Cited by 1,459
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
Eikelboom, J. W., Mehta, S. R., Anand, S. S., Xie, C., Fox, K. A. A., & Yusuf, S. (2006) · Circulation · doi:10.1161/circulationaha.106.612812 · Cited by 1,341
Invited Commentary: Propensity Scores
Joffe, M. M., & Rosenbaum, P. R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010011 · Cited by 1,048
Manoukian, S. V., Feit, F., Mehran, R., Voeltz, M. D., Ebrahimi, R., Hamon, M., Dangas, G. D., Lincoff, A. M., White, H. D., Moses, J. W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.027 · Cited by 798
Bhatt, D. L., Roe, M. T., Peterson, E. D., Li, Y., Chen, A. Y., Harrington, R. A., Greenbaum, A. B., Berger, P. B., Cannon, C. P., Cohen, D. J., et al. (2004) · JAMA · doi:10.1001/jama.292.17.2096 · Cited by 568
Koreny, M., Riedmüller, E., Nikfardjam, M., Siostrzonek, P., & Müllner, M. (2004) · JAMA · doi:10.1001/jama.291.3.350 · Cited by 559
Kinnaird, T. D., Stabile, E., Mintz, G. S., Lee, C. W., Canos, D. A., Gevorkian, N., Pinnow, E. E., Kent, K. M., Pichard, A. D., Satler, L. F., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00972-x · Cited by 542
Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions
Ndrepepa, G., Berger, P. B., Mehilli, J., Seyfarth, M., Neumann, F.-J., Schömig, A., & Kastrati, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.040 · Cited by 471
Using Numerical Results from Systematic Reviews in Clinical Practice
McQuay, H. J., & Moore, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-9-199705010-00007 · Cited by 455
Austin, P. C. (2009) · Medical Decision Making · doi:10.1177/0272989x09341755 · Cited by 454
Mehran, R., Lansky, A. J., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61484-7 · Cited by 418
Brindis, R. G., Fitzgerald, S., Anderson, H. V., Shaw, R. E., Weintraub, W. S., & Williams, J. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01372-9 · Cited by 387
ORDINAL REGRESSION MODELS FOR EPIDEMIOLOGIC DATA
ARMSTRONG, B. G., & SLOAN, M. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115109 · Cited by 320
Chronic Total Occlusion Angioplasty in the United States
Grantham, J. A., Marso, S. P., Spertus, J., House, J., Holmes, D. R., & Rutherford, B. D. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.02.008 · Cited by 302
Self-citationMehta, S. K., Frutkin, A. D., Lindsey, J. B., House, J. A., Spertus, J. A., Rao, S. V., Ou, F.-S., Roe, M. T., Peterson, E. D., & Marso, S. P. (2009) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.108.846741 · Cited by 299
Self-citationRisk-Treatment Mismatch in the Pharmacotherapy of Heart Failure
Lee, D. S. (2005) · JAMA · doi:10.1001/jama.294.10.1240 · Cited by 257
Austin, P. C. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1673 · Cited by 238
Lincoff, A. M., Bittl, J. A., Kleiman, N. S., Sarembock, I. J., Jackman, J. D., Mehta, S., Tannenbaum, M. A., Niederman, A. L., Bachinsky, W. B., Tift-Mann, J., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.033 · Cited by 215
Calculating Confidence Intervals for the Number Needed to Treat
Bender, R. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00134-3 · Cited by 214
The number needed to treat: a clinically useful nomogram in its proper context
Chatellier, G., Zapletal, E., Lemaitre, D., Menard, J., & Degoulet, P. (1996) · BMJ · doi:10.1136/bmj.312.7028.426 · Cited by 205
Arora, N., Matheny, M. E., Sepke, C., & Resnic, F. S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.12.014 · Cited by 191
Pilote, L., Miller, D. P., Califf, R. M., Rao, J. S., Weaver, W. D., & Topol, E. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351606 · Cited by 165
Yan, A. T.-K., Yan, R. T., Huynh, T., Casanova, A., Raimondo, F. E., FITCHETT, D. H., Langer, A., & Goodman, S. G. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.563 · Cited by 126
Cohen, D. J., Lincoff, A. M., Lavelle, T. A., Chen, H.-L., Bakhai, A., Berezin, R. H., Jackman, J. D., Sarembock, I. J., & Topol, E. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.085 · Cited by 119
Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies
Alter, D. A., Manuel, D. G., Gunraj, N., Anderson, G., Naylor, C. D., & Laupacis, A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.039 · Cited by 90
Exploring the Treatment-Risk Paradox in Coronary Disease
McAlister, F. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1019 · Cited by 78
Halon, D. A., Adawi, S., Dobrecky‐Mery, I., & Lewis, B. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.044 · Cited by 75
Predictors of length of stay after coronary stenting
Aronow, H. D., Peyser, P. A., Eagle, K. A., Bates, E., Werns, S. W., Russman, P. L., Crum, M. A., Harris, K., & Moscucci, M. M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.119371 · Cited by 54
Spertus, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430210059009 · Cited by 28
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Authors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., et al. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.11.006 · Cited by 1,068
Metadata
- Authors
- Marso, S. P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-06-02
- Volume
- 303
- Issue
- 21
- Pages
- 2156
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1964365503
- Cited by
- 300
- References
- 39
- FWCI
- 23.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.